Trademark: 76346743
Word
SCAGE
Status
Dead
Status Code
710
Status Date
Friday, November 23, 2012
Serial Number
76346743
Registration Number
3081096
Registration Date
Tuesday, April 18, 2006
Mark Type
1000
Filing Date
Friday, December 7, 2001
Published for Opposition
Tuesday, May 4, 2004
Cancellation Date
Friday, November 23, 2012

Trademark Owner History
Micromet AG - Original Registrant

Classifications
1 Chemical preparations, namely, buffer, polypeptides, nucleic acids for use in scientific experiments; chemical agents for characterizing and examination of diseases, particularly of tumors, coronary heart diseases, particularly restenosis, minimal residual diseases, infectious diseases, autoimmune diseases for scientific purposes; chemical agents for characterizing and examination of eukaryotic cells, namely, animal cells, particularly mammalian cells and human cells, green plant cells, fungi cells, rhodophyta cells, alveolate cells, stramenopiles cells, other protist cells, particularly kinetoplastida and amoeboflagellata, cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples prepared with a laser, of cells isolated with FACS or with receptor/ligand binding, of chemical fixed tissue, of micrometastatic cells, of bone marrow cells, of samples from body fluids, particularly from amniotic fluid, liquor, blood, lymph, urine or bowel movement, of stem cells, cloned single cells or differentiated stages from specific cells for scientific use; eukaryotic cell culture lines, namely, animal cell culture lines, particularly mammalian cell culture lines and human cell culture lines, green plant cell culture lines, fungi cell culture lines, rhodophyta cell culture lines, alveolate cell culture lines, stramenopiles cell culture lines, other protist cell culture lines, particularly kinetoplastida and amoeboflagellata cell culture lines for scientific purposes; cultures of microorganisms for scientific purposes; nucleic acids for scientific purposes
5 Medical diagnostic chemical agents for characterizing and examination of diseases, namely, tumors, coronary heart diseases, particularly restenosis, minimal residual diseases, infectious diseases, autoimmune diseases; pharmaceutical preparations for the treatment of tumors, coronary heart diseases, particularly restenosis, minimal residual diseases, infectious diseases, autoimmune diseases and veterinary preparations for the treatment of pets and farm animals, namely pigs, dogs, cats, ferrets, hoofed animals, particularly horses, cattle, sheep, asses and mules, birds, particularly poultry, particularly chickens, ducks, turkeys and gooses, pigeons, parrots and budgerigars, fishes, small animals, particularly hares, rabbits, hamsters, mice, rats and guinea pigs, reptiles, particularly snakes, frogs, turtles, crocodiles and lizards; pharmaceutical preparations for diagnosis and analysis of tumors; coronary heart diseases, particularly restenosis, minimal residual diseases, infections diseases, autoimmune diseases; pharmaceutical preparations for diagnosis and analysis of eukaryotic cells, mammalian cells and human cells, of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples prepared with a laser, of cells isolated with FACS or with receptor/ligand binding, of cells of chemical fixed tissue, of micrometastatic cells, of bone marrow cells, of samples from body fluids, particularly amniotic fluid, from liquor, blood, lymph, urine or bowel movement, of stem cells, cloned single cells of differentiated stages from specific cells; eukaryotic cell culture lines, namely, animal cell culture lines, particularly mammalian cell culture lines and human cell culture lines, green plant cell culture lines, rhodophyta cell culture lines, alveolate cell culture lines, stramenopiles cell culture lines, protist cell culture lines, fungi cell culture lines for medical purposes; cultures of microorganisms for medical purposes; nucleic acids for medical purposes
9 Diagnostic and testing apparatus and instruments, namely, syringe, needle, biopsy needle, array, particularly DNA-array, array reader, scanner, imaging devices, hybridization machine, hybridization chamber, thermocycler, centrifuge, reaction tubes, centrifuge tubes, filter, rotator, mixer, beads, FACS, laser, particularly laser for microdissections, balloon instrument, magnetic devices for scientific purposes; diagnostic and testing apparatus and instruments, namely, syringe, needle, biopsy needle, array, particularly DNA-array, array reader, scanner, imaging devices, hybridization machine, hybridization chamber, thermocycler, centrifuge, reaction tubes, centrifuge tubes, filter, rotator, mixer, beads, FACS, laser, particularly laser for microdissections, balloon instrument, magnetic devices for the development of medicaments, for the identification of expressed genes, particularly abnormal expressed genes; Diagnostic and testing apparatus and instruments for the analysis of the gene expression patterns of single cells and cell culture lines, mammalian cells and human cells, of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples prepared with a laser, of cells isolated with FACS or with receptor/ligand binding, of chemical fixed tissue, of micrometastatic cells, of bone marrow cells, of samples from body fluids, from amniotic fluid, liquor, blood, lymph, urine or bowel movements, of stem cells, cloned single cells or differentiated stages from specific cells
10 Medical diagnostic instruments, namely, syringe, needle, biopsy needle, array, particularly DNA-array, array reader, scanner, Imaging devices, hybridization machine, hybridization chamber, thermocycler, centrifuge, reaction tubes, centrifuge tubes, filter, rotator, mixer, beads, FACS, laser, particularly laser for microdissections, balloon instrument, magnetic devices for diagnosing tumors, coronary heart diseases, particularly restenosis, minimal residual diseases, infectious diseases, autoimmune diseases; diagnostic and testing apparatus for medical purposes, namely, syringe, needle, biopsy needle, array, particularly DNA-array, array reader, scanner, imaging devices, hybridization machine, hybridization chamber, thermocycler, centrifuge, reaction tubes, centrifuge, tubes, filter, rotator, mixer, beads, FACS, laser, particularly laser for microdissections, balloon instrument, magnetic devices, for testing for eukaryotic cells, cells of microscopic small biopsies, of cells out of tissue samples prepared with a laser, of cells isolated with FACS or with receptor/ligand binding, of chemical fixed tissue, of micrometastatic cells, of bone marrow cells, of samples from body fluids from amniotic fluid, liquor, blood, lymph, urine or bowel movement, of stem cells, cloned single cells or differentiated stages from specific cells of human tissues; medical diagnostic and testing apparatus, namely syringe, needle, biopsy-needle, array, particularly DNA-array, array reader, scanner, imaging devices, hybridization machine, hybridization chamber, thermocycler, centrifuge, reaction tubes, centrifuge tubes, filter, rotator, mixer, bead, FACS, laser, particularly laser for microdissections, balloon instrument, magnetic devices for testing animal cells for veterinary use
42 Medical services; scientific and industrial research in the field of molecular biology, bio-technology, genetics, medicine and pharmacology; medical services, namely, diagnosis of pathogenesis of animal and human diseases, cell differentiation of stem cells and other progenitor cells, steps in the development from micrometastatic cells to metastatic cells, characterization of the differentiated stages from specific cells; identification of target structures for the development of medicaments; medical services for the determination of the influence of various substances on the cell growth, proliferation, differentiation and secretion of molecules in various cell types, characterization of the differentiation of nerve cells; characterization of intracellular signal transduction pathways; determination of the influence of the co-culture of cell lines on the cell growth, proliferation, differentiation and secretion of molecules in various cell types and on differential gene expression; medical services and veterinary medicine; Development of pharmaceuticals; laboratory research in the field of identification of expressed genes, namely, abnormal expressed genes, analysis of the gene expression pattern, single cells and cell culture lines in human and mammalian cells; laboratory research in the field of cells of microscopic small biopsies of animal and human tissues, cells out of tissue samples prepared with a laser, of cells isolated with FACS or with receptor/ligand binding, of chemical fixed tissue, of micrometastatic cells, of bone marrow cells, of samples from body fluids from amniotic fluid, liquor, blood, lymph, urine or bowel movement, of stem cells, cloned single cells, differentiated stages from specific cells; Development of new technology for others in the field of scientific and industrial research

Trademark Events
Nov 23, 2012
Cancelled Sec. 8 (6-Yr)
Apr 18, 2006
Registered-Principal Register
Feb 14, 2006
1(B) Basis Deleted; Proceed To Registration
Jan 27, 2006
Notice Of Allowance Cancelled
Jan 9, 2006
Paper Received
Nov 16, 2005
Fax Received
Sep 7, 2005
Fax Received
Aug 11, 2005
Fax Received
Aug 3, 2005
Extension 2 Granted
Jul 22, 2005
Extension 2 Filed
Jul 22, 2005
Teas Extension Received
Jan 18, 2005
Extension 1 Granted
Jan 18, 2005
Extension 1 Filed
Jan 18, 2005
Teas Extension Received
Jan 10, 2005
Paper Received
Jul 27, 2004
Noa Mailed - Sou Required From Applicant
May 4, 2004
Published For Opposition
Apr 14, 2004
Notice Of Publication
Feb 11, 2004
Approved For Pub - Principal Register
Nov 17, 2003
Correspondence Received In Law Office
Nov 20, 2003
Paper Received
Nov 5, 2003
Case File In Ticrs
May 22, 2003
Final Refusal Mailed
Mar 17, 2003
Correspondence Received In Law Office
Mar 17, 2003
Paper Received
Jan 3, 2003
Letter Of Suspension Mailed
Oct 22, 2002
Correspondence Received In Law Office
Oct 25, 2002
Correspondence Received In Law Office
Oct 25, 2002
Paper Received
Apr 24, 2002
Non-Final Action Mailed
Apr 17, 2002
Assigned To Examiner
Jan 22, 2002
Correspondence Received In Law Office

Trademark Alertz updated from USPTO on 2030-01-24